Frédéric Charlotte

Overview

Best Publications

• Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

  Vlad Ratziu;Frédéric Charlotte;Agnès Heurtier;Sophie Gombert

  2233
  Citations

• Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study

  Françoise Imbert-Bismut;Vlad Ratziu;Laurence Pieroni;Frederic Charlotte

  1926
  Citations

• Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

  Y Benhamou;M Bochet;V Di Martino;F Charlotte

  1646
  Citations

• Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

  Jean-François Emile;Oussama Abla;Sylvie Fraitag;Annacarin Horne

  1598
  Citations

• Liver fibrosis in overweight patients.

  Vlad Ratziu;Philippe Giral;Frederic Charlotte;Eric Bruckert

  1322
  Citations

• Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C

  Thierry Poynard;Vlad Ratziu;Frédéric Charlotte;Zachary Goodman

  981
  Citations

• Extrahepatic manifestations of chronic hepatitis C

  Patrice Cacoub;Thierry Poynard;Pascale Ghillani;Frederic Charlotte

  896
  Citations

• Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

  Vlad Ratziu;Philippe Giral;Sophie Jacqueminet;Fréderic Charlotte

  725
  Citations

• High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

  Julien Haroche;Frédéric Charlotte;Laurent Arnaud;Andreas von Deimling

  692
  Citations

• Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

  Julien Haroche;Fleur Cohen-Aubart;Jean-François Emile;Laurent Arnaud

  605
  Citations

• 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

  A J Demetris;C Bellamy;S G Hübscher;J O'Leary

  604
  Citations

• Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis

  Vlad Ratziu;Luminita Bonyhay;Vincent Di Martino;Frederic Charlotte

  601
  Citations

• Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.

  Aurélie Trenado;Frédéric Charlotte;Sylvain Fisson;Micael Yagello

  591
  Citations

• Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.

  Vlad Ratziu;Julien Massard;Frederic Charlotte;Djamila Messous

  587
  Citations

• A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

  Raluca Pais;Fréderic Charlotte;Larissa Fedchuk;Pierre Bedossa

  567
  Citations

• Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice

  Muriel Sudres;Françoise Norol;Aurélie Trenado;Sylvie Grégoire

  522
  Citations

• Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

  V Leblond;F Davi;F Charlotte;R Dorent

  502
  Citations

• Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

  Oussama Abla;Eric Jacobsen;Jennifer Picarsic;Zdenka Krenova

  500
  Citations

• Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

  Karim Belhadj;Felix Reyes;Jean-Pierre Farcet;Herve Tilly

  496
  Citations

• Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.

  Vlad Ratziu;Vlad Ratziu;Fréderic Charlotte;Carole Bernhardt;Philippe Giral

  476
  Citations